Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stroke Prevention in Patients With Atrial Fibrillation”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Post-approval studies (Phase 4)WithdrawnNCT01668901
What this trial is testing

Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease

Who this might be right for
Atrial FibrillationChronic Kidney Disease
Seoul National University Hospital
Post-approval studies (Phase 4)Not Yet RecruitingNCT07237308
What this trial is testing

BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis

Who this might be right for
StrokeIschemicAtrial Fibrillation+2 more
Yonsei University 586
Not applicableNot Yet RecruitingNCT07455539
What this trial is testing

LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Prince of Wales Hospital, Shatin, Hong Kong 10
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Not applicableStudy completedNCT01606995
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 6,784
Not applicableStudy completedNCT02684981
What this trial is testing

Patient Convenience Study (RE-SONANCE)

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 9,472
Not applicableUnknownNCT04180605
What this trial is testing

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Rigshospitalet, Denmark 200
Not applicableLooking for participantsNCT06324188
What this trial is testing

Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)

Who this might be right for
Atrial Fibrillation
Atrial Fibrillation Network 2,312
Not applicableStudy completedNCT03284762
What this trial is testing

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 1,216
Testing effectiveness (Phase 2)Study completedNCT01227629
What this trial is testing

PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 502
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Not applicableStudy completedNCT02597920
What this trial is testing

Patient Convenience Study

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,852
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Not applicableStudy completedNCT01927445
What this trial is testing

Improving Stroke Prevention Therapy for Patients With Atrial Fibrillation in Primary Care

Who this might be right for
Atrial Fibrillation
Sunnybrook Health Sciences Centre 5,000
Not applicableStudy completedNCT02478294
What this trial is testing

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke

Who this might be right for
Atrial FibrillationStrokeSystemic Embolism
The First Affiliated Hospital with Nanjing Medical University 474
Not applicableStudy completedNCT01090362
What this trial is testing

Global Anticoagulant Registry in the Field

Who this might be right for
Atrial Fibrillation
Thrombosis Research Institute 57,250
Not applicableStudy completedNCT02240667
What this trial is testing

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,506
Not applicableStudy completedNCT02262676
What this trial is testing

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Who this might be right for
Atrial Fibrillation
Bayer 2,251
Large-scale testing (Phase 3)Ended earlyNCT00580216
What this trial is testing

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sanofi 3,773
Load More Results